Voxel S.A. (0NX.F)

21.30 -0.50 (-2.29%) At close: 08:01AM CEST

Voxel S.A.

ul. Wielicka 265
Kraków 30-663
Poland
48 12 651 1302
https://www.voxel.pl

Sector(s): Healthcare
Industry: Diagnostics & Research
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Jaroslaw Furdal	Chairman of the Management Board	660k	N/A	N/A
Grzegorz Rutkowski	Vice Chairman of the Management Board	648k	N/A	N/A

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Voxel S.A. operates a network of diagnostic imaging laboratories in Poland. The company operates in Diagnostics, Therapy, and IT segments. The company provides diagnostic imaging services, which include magnetic resonance imaging scans, computed tomography scans, and positron emission tomography; teleradiology services; and neuroradiosurgery services. It is also involved in nuclear medicine research. In addition, it operates neurological hospitals, laboratories for COVID-19 diagnostics, and information systems for hospitals; and offers clinical test services. Further, it produces and sells radiopharmaceuticals products. Voxel S.A. was incorporated in 2005 and is based in Kraków, Poland.

Corporate Governance

Voxel S.A.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.